Mical Paul is a clinician heading the Infectious Diseases division at Rambam Health Care Campus and a Professor at the Faculty of Medicine, Technion, Israel Institute of Technology.

Her research is clinical and epidemiological, and she has led numerous Cochrane and other systematic reviews. Her research focuses on multidrug-resistant Gram-negative bacteria, hospital-acquired infections, and phase IV antibiotic trials. She also specializes in methodological study design, risk of bias assessment, meta-analysis and evidence grading. She has participated in previous WHO guideline development groups on iron supplementation (nutritional action group), the advisory committee on the clinical development pipeline of antibacterial treatments and the scientific group developing target product profiles for needed antibacterial treatments.

Mical is an editor with Clinical Microbiology and Infection and the Cochrane Infectious Diseases Group. She is also a member of The Israeli National Academy of Science in Medicine, a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) fellow, and a past chairperson of ESCMID’s study group on infections in the elderly, an ESCMID guidelines sub-committee member and a methodologist support for WHO and ESCMID guidelines development.